Unknown

Dataset Information

0

Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy.


ABSTRACT: Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) plays a central role in the pathogenesis of diabetes. This protein has been recognized as a potential target for diabetic therapy. In this study, we identified astragaloside IV (AS-IV) as a potent modulator of SERCA inhibiting renal injury in diabetic status. Increasing doses of AS-IV (2, 6, and 18 mg kg-1 day-1) were administered intragastrically to db/db mice for 8 weeks. Biochemical and histopathological approaches were conducted to evaluate the therapeutic effects of AS-IV. Cultured mouse podocytes were used to further explore the underlying mechanism in vitro. AS-IV dose-dependently increased SERCA activity and SERCA2 expression, and suppressed ER stress-mediated and mitochondria-mediated apoptosis in db/db mouse kidney. AS-IV also normalized glucose tolerance and insulin sensitivity, improved renal function, and ameliorated glomerulosclerosis and renal inflammation in db/db mice. In palmitate stimulated podocytes, AS-IV markedly improved inhibitions of SERCA activity and SERCA2 expression, restored intracellular Ca2+ homeostasis, and attenuated podocyte apoptosis in a dose-dependent manner with a concomitant abrogation of ER stress as evidenced by the downregulation of GRP78, cleaved ATF6, phospho-IRE1? and phospho-PERK, and the inactivation of both ER stress-mediated and mitochondria-mediated apoptotic pathways. Furthermore, SERCA2b knockdown eliminated the effect of AS-IV on ER stress and ER stress-mediated apoptotic pathway, whereas its overexpression exhibited an anti-apoptotic effect. Our data obtained from in vivo and in vitro studies demonstrate that AS-IV attenuates renal injury in diabetes subsequent to inhibiting ER stress-induced podocyte apoptosis through restoring SERCA activity and SERCA2 expression.

SUBMITTER: Guo H 

PROVIDER: S-EPMC5174081 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca<sup>2+</sup>-ATPase 2 Expression in Diabetic Nephropathy.

Guo Hengjiang H   Cao Aili A   Chu Shuang S   Wang Yi Y   Zang Yingjun Y   Mao Xiaodong X   Wang Hao H   Wang Yunman Y   Liu Cheng C   Zhang Xuemei X   Peng Wen W  

Frontiers in pharmacology 20161221


Sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) plays a central role in the pathogenesis of diabetes. This protein has been recognized as a potential target for diabetic therapy. In this study, we identified astragaloside IV (AS-IV) as a potent modulator of SERCA inhibiting renal injury in diabetic status. Increasing doses of AS-IV (2, 6, and 18 mg kg<sup>-1</sup> day<sup>-1</sup>) were administered intragastrically to <i>db/db</i> mice for 8 weeks. Biochemical and histopathological a  ...[more]

Similar Datasets

| S-EPMC3288054 | biostudies-literature
| S-EPMC8155808 | biostudies-literature
| S-EPMC3397473 | biostudies-literature
| S-EPMC7723158 | biostudies-literature
| S-EPMC2699374 | biostudies-literature
| S-EPMC1218103 | biostudies-other
| S-EPMC7072167 | biostudies-literature
| S-EPMC2984194 | biostudies-literature
| S-EPMC1422767 | biostudies-literature
| S-EPMC3663555 | biostudies-literature